The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
Open accessAbstract
Recent studies identified a short peptide motif that serves as a docking site for cyclin/cyclin-dependent kinase (cdk) 2 complexes . Peptides containing this motif block the phosphorylation of substrates by cyclin A/cdk2 or cyclin E/cdk2. Here we report that cell membrane-permeable forms of such peptides preferentially induced transformed cells to undergo apoptosis relative to nontransformed cells. Deregulation of E2F family transcription factors is a common event during transformation and was sufficient to sensitize cells to the cyclin/cdk2 inhibitory peptides. These results suggest that deregulation of E2F and inhibition of cdk2 are synthetically lethal and provide a rationale for the development of cdk2 antagonists as antineoplastic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
Tat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943
Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., & Dowdy, S. F. (1998) · Nature Medicine · doi:10.1038/4042 · Cited by 928
Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907
p53 and E2F-1 cooperate to mediate apoptosis.
Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 839
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 756
Self-citationDeregulated expression of E2F-1 induces S-phase entry and leads to apoptosis.
Shan, B., & Lee, W. H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8166 · Cited by 530
Johnson, D. G., Ohtani, K., & Nevins, J. R. (1994) · Genes & Development · doi:10.1101/gad.8.13.1514 · Cited by 494
KREK, W. (1994) · Cell · doi:10.1016/0092-8674(94)90582-7 · Cited by 492
The retinoblastoma protein binds to a family of E2F transcription factors.
Lees, J. A., Saito, M., Vidal, M., Valentine, M., Look, T., Harlow, E., Dyson, N., & Helin, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7813 · Cited by 441
Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
Dynlacht, B. D., Flores, O., Lees, J. A., & Harlow, E. (1994) · Genes & Development · doi:10.1101/gad.8.15.1772 · Cited by 395
Adams, P. D., Sellers, W. R., Sharma, S. K., Wu, A. D., Nalin, C. M., & Kaelin, W. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6623 · Cited by 373
Self-citationSubstrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A
Schulman, B. A., Lindstrom, D. L., & Harlow, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10453 · Cited by 372
Krek, W., Xu, G., & Livingston, D. M. (1995) · Cell · doi:10.1016/0092-8674(95)90141-8 · Cited by 354
Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts.
Pagano, M., Pepperkok, R., Lukas, J., Baldin, V, Ansorge, W., Bartek, J., & Draetta, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.101 · Cited by 322
Cyclin-Binding Motifs Are Essential for the Function of p21 CIP1
Chen, J., Saha, P., Kornbluth, S., Dynlacht, B. D., & Dutta, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4673 · Cited by 320
The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
Tsai, L., Lees, E. M., Faha, B., Harlow, E. E., & Riabowol, K. T. (1993) · PubMed · Cited by 310
Xu, M., Sheppard, K. A., Peng, C. Y., Yee, A. S., & Piwnica-Worms, H. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8420 · Cited by 293
Hsieh, J. K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lu, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278
Induction of DNA synthesis and apoptosis are separable functions of E2F-1.
Phillips, A. C., Bates, S., Ryan, K. M., Helin, K., & Vousden, K. H. (1997) · Genes & Development · doi:10.1101/gad.11.14.1853 · Cited by 259
Role of the retinoblastoma protein in the pathogenesis of human cancer.
Sellers, W. R., & Kaelin, W. G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.11.3301 · Cited by 253
Self-citation(1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4660 · Cited by 247
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Hsiao, K. M., McMahon, S. L., & Farnham, P. J. (1994) · Genes & Development · doi:10.1101/gad.8.13.1526 · Cited by 239
Sears, R., Ohtani, K., & Nevins, J. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5227 · Cited by 214
RNA-RNA interactions in the spliceosome: Unraveling the ties that bind
Nilsen, T. W. (1994) · Cell · doi:10.1016/0092-8674(94)90563-0 · Cited by 210
Fueyo, J., Gomez-Manzano, C., Yung, W. K. A., Liu, T. J., Alemany, R., McDonnell, T. J., Shi, X., Rao, J. S., Levin, V. A., & Kyritsis, A. P. (1998) · Nature Medicine · doi:10.1038/nm0698-685 · Cited by 175
Fåhraeus, R., Paramio, J. M., Ball, K. L., Laín, S., & Lane, D. P. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00425-6 · Cited by 170
Unrestricted cell cycling and cancer
Strauss, M., Lukas, J., & Bartek, J. (1995) · Nature Medicine · doi:10.1038/nm1295-1245 · Cited by 158
Neuman, E., Flemington, E. K., Sellers, W. R., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6607-6615.1994 · Cited by 73
Cited by
Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“(Chen et al., 1999), which might show particular promise in tumors with elevated E2F activity (Figure 3).”
BackgroundTo cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Metadata
- Authors
- Chen, Y.-N. P., Sharma, S. K., Ramsey, T. M., Jiang, L., Martin, M. S., Baker, K., Adams, P. D., Bair, K. W., & Kaelin, W. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-04-13
- Volume
- 96
- Issue
- 8
- Pages
- 4325-4329
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2025618547
- Cited by
- 314
- References
- 31
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.